Maxim Kholin

Co-founder at GERO, a pioneering company using physics-based generative models and AI-guided drug design on human health records. My mission is to develop transformative interventions for aging and age-related diseases.

Maxim Kholin is a prominent figure in the biotech industry, known for co-founding two successful companies: Gero and Quantum Pharmaceuticals.

At Gero, Maxim spearheads business development and cultivates strategic partnerships to revolutionize the field of anti-aging treatments and longevity.

Gero.ai, a forward-thinking biotech firm, integrates AI technology to combat aging and chronic diseases using innovative Large Health Models (LHMs) based on physics-driven machine learning to forecast health outcomes.

Collaborations with renowned institutions such as Harvard Medical School and partnerships with industry giants like Pfizer underscore Maxim's commitment to pioneering drug discovery and enhancing human healthspan.

Having obtained an M.A. in Financial Management from Moscow Financial University, Maxim combines business acumen with a passion for healthcare innovation, making him a driving force in the biotech landscape.